24/08/2026
๐ ๐บ๐ฒ๐บ๐ผ๐ฟ๐ฎ๐ฏ๐น๐ฒ ๐ฎ๐ป๐ฑ ๐ฑ๐ฒ๐ฒ๐ฝ๐น๐ ๐ต๐๐บ๐ฏ๐น๐ถ๐ป๐ด ๐ฑ๐ฎ๐ ๐ฎ๐ ๐๐ต๐ฟ๐ถ๐๐๐ถ๐ฎ๐ป ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ผ๐น๐น๐ฒ๐ด๐ฒ (๐๐ ๐), ๐ฉ๐ฒ๐น๐น๐ผ๐ฟ๐ฒ.
It was a great ๐ฝ๐ฟ๐ถ๐๐ถ๐น๐ฒ๐ด๐ฒ ๐๐ผ ๐ฏ๐ฒ ๐ถ๐ป๐๐ถ๐๐ฒ๐ฑ ๐ฎ๐ ๐๐ต๐ฒ ๐๐ต๐ถ๐ฒ๐ณ ๐๐๐ฒ๐๐ ๐ฎ๐ ๐๐๐ฆ๐๐ข๐ก ๐ฎ๐ฌ๐ฎ๐ฒ, ๐๐ต๐ฒ ๐ญ๐ฒ๐๐ต ๐๐ป๐ป๐๐ฎ๐น ๐๐ผ๐ป๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒ ๐ผ๐ณ ๐๐ต๐ฒ ๐๐ป๐ฑ๐ถ๐ฎ๐ป ๐๐ฟ๐ฎ๐ฐ๐ต๐๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ ๐ฆ๐ผ๐ฐ๐ถ๐ฒ๐๐, ๐ฎ๐ป๐ฑ ๐๐ผ ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ ๐ฎ ๐น๐ฒ๐ฐ๐๐๐ฟ๐ฒ ๐ผ๐ป โ๐๐ฟ๐ฎ๐ฐ๐ต๐๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ ๐ถ๐ป ๐ข๐ฝ๐ต๐๐ต๐ฎ๐น๐บ๐ถ๐ฐ ๐ง๐๐บ๐ผ๐๐ฟ๐.โ
Visiting one of Indiaโs most prestigious and respected institutions, CMC Vellore, was a truly special experience. I am deeply honoured to have been felicitated by the distinguished heads and faculty of the institution.
๐๐ฟ๐ฎ๐ฐ๐ต๐๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ has a unique and invaluable role in the management of several ophthalmic malignancies, offering the possibility of precise, highly localised treatment while preserving the eye and, whenever possible, vision. It has been a privilege to share my experience and learn alongside colleagues dedicated to advancing cancer care.
My sincere gratitude to the Indian Brachytherapy Society and the entire CMC Vellore team for this honour and for their warm hospitality.
An honour to be invited. A privilege to share. And an even greater responsibility to continue advancing cancer care with precision, personalisation and compassion.
Vellore